PE20080233A1 - Suspension acuosa estable antiinflamatoria - Google Patents

Suspension acuosa estable antiinflamatoria

Info

Publication number
PE20080233A1
PE20080233A1 PE2007000600A PE2007000600A PE20080233A1 PE 20080233 A1 PE20080233 A1 PE 20080233A1 PE 2007000600 A PE2007000600 A PE 2007000600A PE 2007000600 A PE2007000600 A PE 2007000600A PE 20080233 A1 PE20080233 A1 PE 20080233A1
Authority
PE
Peru
Prior art keywords
aqueous suspension
suspension
stable anti
inflammatory
sweeteners
Prior art date
Application number
PE2007000600A
Other languages
English (en)
Inventor
Lillian Cromie
Willy Blakely
Louise Reynolds
Original Assignee
Norbrook Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38170964&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20080233(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0610058A external-priority patent/GB0610058D0/en
Priority claimed from GB0610246A external-priority patent/GB0610246D0/en
Application filed by Norbrook Lab Ltd filed Critical Norbrook Lab Ltd
Publication of PE20080233A1 publication Critical patent/PE20080233A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

REFERIDA UNA SUSPENSION FARMACEUTICA ACUOSA QUE COMPRENDE: UN FARMACO ANTIINFLAMATORIO NO ESTEROIDEO, UN SISTEMA TAMPONANTE ACUOSO, GOMA XANTANO EN UNA CANTIDAD DE 0,4% p/v DE LA SUSPENSION, POLIVINILPIRROLIDONA EN UNA CANTIDAD DE ENTRE 1% Y 2,2% p/v DE LA SUSPENSION, GLICEROL EN UNA CANTIDAD DE ENTRE 10% Y 30% p/v DE LA SUSPENSION Y AGENTES MODIFICADORES DEL SABOR TALES COMO EDULCORANTES DE CARGA, EDULCORANTES INTENSOS, AGENTES SABORIZANTES Y MEZCLAS DE ELLOS, DONDE DICHA SUSPENSION CARECE DE ALMIDON PREGELATINIZADO, ACIDO AMINO POLICARBOXILICO, CELULOSA MICROCRISTALINA, HIDROXIPROPILMETILCELULOSA, MONOOLEATO DE POLIOXIETILEN SORBITAN Y DIOXIDO DE SILICIO. DENTRO DE LOS FARMACOS ANTIINFLAMATORIOS SE ENCUENTRAN OXICAMS, ACIDOS FENAMICOS, SALICILATOS, DERIVADOS DEL ACIDO PROPIONICO, ENTRE OTROS, DE PREFERENCIA SON PIROXICAM, MELOXICAM, CARPROFENO E IBUPROFENO. DICHA SUSPENSION ES UTIL EN EL TRATAMIENTO DE ENFERMEDADES INFLAMATORIAS E INFECCIOSAS
PE2007000600A 2006-05-19 2007-05-17 Suspension acuosa estable antiinflamatoria PE20080233A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0610058A GB0610058D0 (en) 2006-05-19 2006-05-19 Stable aqueous suspension
GB0610246A GB0610246D0 (en) 2006-05-23 2006-05-23 Stable aqueous suspension
GB0708375A GB2438287A (en) 2006-05-19 2007-04-30 Stable aqueous suspension

Publications (1)

Publication Number Publication Date
PE20080233A1 true PE20080233A1 (es) 2008-04-10

Family

ID=38170964

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007000600A PE20080233A1 (es) 2006-05-19 2007-05-17 Suspension acuosa estable antiinflamatoria

Country Status (16)

Country Link
US (1) US9399013B2 (es)
JP (2) JP5391063B2 (es)
KR (1) KR101452721B1 (es)
AT (1) ATE446740T1 (es)
CR (1) CR10429A (es)
DE (1) DE602007003026D1 (es)
DK (1) DK2034958T3 (es)
EA (1) EA015301B1 (es)
ES (1) ES2335622T3 (es)
GB (1) GB2438287A (es)
IL (1) IL194244A (es)
MX (1) MX2008011775A (es)
NZ (1) NZ572380A (es)
PE (1) PE20080233A1 (es)
PT (1) PT2034958E (es)
SI (1) SI2034958T1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6050564B2 (ja) * 2010-03-11 2016-12-21 テイカ製薬株式会社 フィルム状製剤
GB201117858D0 (en) * 2011-10-17 2011-11-30 Norbrook Lab Ltd Paste
FI126442B (en) * 2011-11-01 2016-12-15 Valio Oy Liquid enzyme preparation and process for its preparation
EP3673897A4 (en) * 2017-08-24 2021-05-05 Jiangsu Hengrui Medicine Co., Ltd. INJECTABLE PHARMACEUTICAL COMPOSITION WITH MELOXICAM AND METHOD FOR MANUFACTURING IT
KR102145022B1 (ko) * 2018-08-14 2020-08-14 동아제약 주식회사 이부프로펜의 현탁액 조성물 및 투여 제형
US20210093642A1 (en) * 2019-09-26 2021-04-01 Cadila Healthcare Limited STABLE AQUEOUS PARENTERAL SOLUTIONS OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs)

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2756113A1 (de) 1977-12-16 1979-06-21 Thomae Gmbh Dr K Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
NZ234143A (en) * 1989-06-28 1991-10-25 Mcneil Ppc Inc Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
CA2033634A1 (en) 1990-01-12 1991-07-13 Takao Ikariya Method of manufacturing aromatic urethane
JPH0714872B2 (ja) * 1990-02-06 1995-02-22 昭和薬品化工株式会社 シロップ剤組成物
US5183829A (en) 1991-09-27 1993-02-02 Applied Analytical Industries, Inc. Oral liquid compositions of non-steroidal anti-inflammatory drugs
US5272137A (en) 1992-02-14 1993-12-21 Mcneil-Pfc, Inc. Aqueous pharmaceutical suspension for pharmaceutical actives
KR940003066A (ko) 1992-07-07 1994-02-19 김주용 콘택홀 접속방법
EP0620001A1 (en) 1993-04-16 1994-10-19 McNEIL-PPC, INC. Aqueous pharmaceutical suspension and process for preparation thereof
IL123505A (en) * 1996-07-08 2004-12-15 Penwest Pharmaceuticals Compan Sustained release matrix for high-dose insoluble drugs
IT1286496B1 (it) 1996-11-20 1998-07-15 Leetrim Ltd Dublin Composizione farmaceutica orale ad attivita' antipiretica,analgesica ed antiinfiammatoria
JP4234666B2 (ja) * 1997-03-28 2009-03-04 エーザイ・アール・アンド・ディー・マネジメント株式会社 苦味等を隠蔽した経口薬剤
US6184220B1 (en) 1998-03-27 2001-02-06 Boehringer Ingelheim Pharma Kg Oral suspension of pharmaceutical substance
EP0945131A1 (de) * 1998-03-27 1999-09-29 Boehringer Ingelheim Pharma KG Perorale Wirkstoff-Suspension
US6268356B1 (en) 1998-04-20 2001-07-31 Pharmaceutical Resources, Inc. Flocculated suspension of megestrol acetate
JP4073121B2 (ja) 1998-08-28 2008-04-09 エーザイ・アール・アンド・ディー・マネジメント株式会社 薬物の苦味等を軽減した組成物
JP2000119198A (ja) * 1998-10-16 2000-04-25 Eisai Co Ltd 苦味等の隠蔽されたホスフォジエステラーゼ阻害剤含有経口製剤
BR0009557A (pt) 1999-04-06 2002-05-28 Ethypharm Lab Prod Ethiques Suspensão farmacêutica para beber de ibuprofeno
US7101572B2 (en) 2001-12-07 2006-09-05 Unilab Pharmatech, Ltd. Taste masked aqueous liquid pharmaceutical composition
US20040258716A1 (en) 2002-06-17 2004-12-23 Shen Gao Ibuprofen suspension
US8512727B2 (en) * 2003-03-03 2013-08-20 Alkermes Pharma Ireland Limited Nanoparticulate meloxicam formulations
US20050069590A1 (en) * 2003-09-30 2005-03-31 Buehler Gail K. Stable suspensions for medicinal dosages
AU2005313365A1 (en) * 2004-12-06 2006-06-15 Janssen Pharmaceutica N.V. Oral suspension comprising meloxicam

Also Published As

Publication number Publication date
SI2034958T1 (sl) 2010-02-26
JP5391063B2 (ja) 2014-01-15
EA015301B1 (ru) 2011-06-30
US20090186883A1 (en) 2009-07-23
DE602007003026D1 (de) 2009-12-10
GB0708375D0 (en) 2007-06-06
EA200870546A1 (ru) 2009-04-28
IL194244A (en) 2011-12-29
ATE446740T1 (de) 2009-11-15
KR20090023607A (ko) 2009-03-05
GB2438287A (en) 2007-11-21
KR101452721B1 (ko) 2014-10-21
CR10429A (es) 2008-12-01
MX2008011775A (es) 2008-10-01
ES2335622T3 (es) 2010-03-30
JP2013241422A (ja) 2013-12-05
JP2009537495A (ja) 2009-10-29
PT2034958E (pt) 2010-01-04
NZ572380A (en) 2011-10-28
DK2034958T3 (da) 2010-03-15
US9399013B2 (en) 2016-07-26

Similar Documents

Publication Publication Date Title
WO2007135362A3 (en) Stable aqueous suspension having palatable taste
CR10429A (es) Suspension acuosa estable
NO20081942L (no) Karbamoylbenzotriazolderivater som inhibitorer av lipaser og fosfolipaser
NO20063925L (no) Indazolderivater som inhibitorer av hormonsensitiv lipase
CY1109391T1 (el) Παραγωγα του υδροξαμικου οξεος, αναστολεις του ενζυμου ιστονοδεακετυλαση, που χρησιμοποιουνται ως νεα αντιφλεγμονωδη φαρμακα αναστολεις της συνθεσης της κιτοκινης
NO20082159L (no) Triazolopyridinderivater som inhibitorer av lipaser og fosfolipaser
NO20091395L (no) Nye tiofenderivater
NO20025430D0 (no) Farmasöytisk aktive piperidinderivater, spesielt som modulatorer av kjemokinreseptoraktivitet
NO20051427L (no) Fremgangsmate for produksjon av hydroksyalkyl stivelsesderivater
NO20044731L (no) Kinolin- og isokinolinderivater fremgangsmate for fremstilling derav og anvendelse derav som betennelseshemmere
NO20054848L (no) Substituerte p-diaminobenzenderivater
NO20060717L (no) Sykliske derivater som modulatorer av kjemokin reseptoractivitet
NO20054015L (no) Hurtige absorpsjons selektive 5-HT agonist formuleringer.
NO20043101L (no) Farmasoytiske blandinger av oralt aktive taxanderivater som har forsterket biotilgjenglighet
NO20040356L (no) Indaneddiksyrederivater og deres andvendelse som farmasoytiske midler, intermediater og fremgangsmate for fremstilling.
EA200800360A1 (ru) Формуляции с высоким содержанием лекарства и дозированные формы
NO20064190L (no) Preparat for oral administrering av tamsulosin-hydroklorid og granuler med kontrollert frigivelsesformulering omfattende det samme
NO20090764L (no) 4-hydroksytiobenzamidderivater og legemidler
MXPA05010174A (es) Derivados de indol e indolina sustituidos.
CY1109320T1 (el) Σκευασμα εναιωρηματος φεξοφεναδινης
EA200401227A1 (ru) Система доставки лекарства с контролируемым высвобождением, включающая правастатин
NO20052408D0 (no) Farmasoytisk formulering av olanzapin
NO20045660L (no) N-((3okso-2,3-dihydro-IH-isoindol-1-yl)acetyl)guanidinderivater som NHE-1-inhibitorer for behandling av infarkt og angina pectoris
NO20055257L (no) Ny fremgangsmate for syntesen av s-indolin-2-karboksylsyre og anvendelse derav i syntesen av perindopril
NO20045385L (no) Farmasoytisk preparat inneholdende okskarbazepin med kontrollert frigivelse av aktivt stoff

Legal Events

Date Code Title Description
FD Application declared void or lapsed